Global and China Combination Antibody Therapy Market Size, Status and Forecast 2020-2026
SKU ID : QYR-16371760 | Publishing Date : 04-Sep-2020
Detailed TOC of Global and China Combination Antibody Therapy Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Combination Antibody Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy/Antibody
1.2.3 Antibody/Antibody
1.2.4 Conjugated Antibodies
1.2.5 Bispecific Antibodies
1.3 Market by Application
1.3.1 Global Combination Antibody Therapy Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Clinics
1.3.5 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Combination Antibody Therapy Market Perspective (2015-2026)
2.2 Global Combination Antibody Therapy Growth Trends by Regions
2.2.1 Combination Antibody Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Combination Antibody Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Combination Antibody Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Combination Antibody Therapy Players by Market Size
3.1.1 Global Top Combination Antibody Therapy Players by Revenue (2015-2020)
3.1.2 Global Combination Antibody Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Combination Antibody Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Combination Antibody Therapy Revenue
3.4 Global Combination Antibody Therapy Market Concentration Ratio
3.4.1 Global Combination Antibody Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Combination Antibody Therapy Revenue in 2019
3.5 Key Players Combination Antibody Therapy Area Served
3.6 Key Players Combination Antibody Therapy Product Solution and Service
3.7 Date of Enter into Combination Antibody Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Combination Antibody Therapy Breakdown Data by Type (2015-2026)
4.1 Global Combination Antibody Therapy Historic Market Size by Type (2015-2020)
4.2 Global Combination Antibody Therapy Forecasted Market Size by Type (2021-2026)
5 Combination Antibody Therapy Breakdown Data by Application (2015-2026)
5.1 Global Combination Antibody Therapy Historic Market Size by Application (2015-2020)
5.2 Global Combination Antibody Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Combination Antibody Therapy Market Size (2015-2026)
6.2 North America Combination Antibody Therapy Market Size by Type (2015-2020)
6.3 North America Combination Antibody Therapy Market Size by Application (2015-2020)
6.4 North America Combination Antibody Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Combination Antibody Therapy Market Size (2015-2026)
7.2 Europe Combination Antibody Therapy Market Size by Type (2015-2020)
7.3 Europe Combination Antibody Therapy Market Size by Application (2015-2020)
7.4 Europe Combination Antibody Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Combination Antibody Therapy Market Size (2015-2026)
8.2 China Combination Antibody Therapy Market Size by Type (2015-2020)
8.3 China Combination Antibody Therapy Market Size by Application (2015-2020)
8.4 China Combination Antibody Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Combination Antibody Therapy Market Size (2015-2026)
9.2 Japan Combination Antibody Therapy Market Size by Type (2015-2020)
9.3 Japan Combination Antibody Therapy Market Size by Application (2015-2020)
9.4 Japan Combination Antibody Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Combination Antibody Therapy Market Size (2015-2026)
10.2 Southeast Asia Combination Antibody Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Combination Antibody Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Combination Antibody Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Combination Antibody Therapy Introduction
11.1.4 Biogen Revenue in Combination Antibody Therapy Business (2015-2020))
11.1.5 Biogen Recent Development
11.2 Roche Holdings
11.2.1 Roche Holdings Company Details
11.2.2 Roche Holdings Business Overview
11.2.3 Roche Holdings Combination Antibody Therapy Introduction
11.2.4 Roche Holdings Revenue in Combination Antibody Therapy Business (2015-2020)
11.2.5 Roche Holdings Recent Development
11.3 Seattle Genetics
11.3.1 Seattle Genetics Company Details
11.3.2 Seattle Genetics Business Overview
11.3.3 Seattle Genetics Combination Antibody Therapy Introduction
11.3.4 Seattle Genetics Revenue in Combination Antibody Therapy Business (2015-2020)
11.3.5 Seattle Genetics Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Combination Antibody Therapy Introduction
11.4.4 Amgen Revenue in Combination Antibody Therapy Business (2015-2020)
11.4.5 Amgen Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Combination Antibody Therapy Introduction
11.5.4 Bristol-Myers Squibb Revenue in Combination Antibody Therapy Business (2015-2020)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Combination Antibody Therapy Introduction
11.6.4 Eli Lilly Revenue in Combination Antibody Therapy Business (2015-2020)
11.6.5 Eli Lilly Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Combination Antibody Therapy Introduction
11.7.4 Novartis Revenue in Combination Antibody Therapy Business (2015-2020)
11.7.5 Novartis Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Combination Antibody Therapy Introduction
11.8.4 Sanofi Revenue in Combination Antibody Therapy Business (2015-2020)
11.8.5 Sanofi Recent Development
11.9 Celgene
11.9.1 Celgene Company Details
11.9.2 Celgene Business Overview
11.9.3 Celgene Combination Antibody Therapy Introduction
11.9.4 Celgene Revenue in Combination Antibody Therapy Business (2015-2020)
11.9.5 Celgene Recent Development
11.10 Genmab
11.10.1 Genmab Company Details
11.10.2 Genmab Business Overview
11.10.3 Genmab Combination Antibody Therapy Introduction
11.10.4 Genmab Revenue in Combination Antibody Therapy Business (2015-2020)
11.10.5 Genmab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China Combination Antibody Therapy Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Global Combination Antibody Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy/Antibody
Table 4. Key Players of Antibody/Antibody
Table 5. Key Players of Conjugated Antibodies
Table 6. Key Players of Bispecific Antibodies
Table 7. Global Combination Antibody Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Combination Antibody Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Combination Antibody Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Combination Antibody Therapy Market Share by Regions (2015-2020)
Table 11. Global Combination Antibody Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Combination Antibody Therapy Market Share by Regions (2021-2026)
Table 13. Combination Antibody Therapy Market Market Trends
Table 14. Combination Antibody Therapy Market Drivers
Table 15. Combination Antibody Therapy Market Challenges
Table 16. Combination Antibody Therapy Market Restraints
Table 17. Global Combination Antibody Therapy Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Combination Antibody Therapy Market Share by Players (2015-2020)
Table 19. Global Top Combination Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Combination Antibody Therapy as of 2019)
Table 20. Global Combination Antibody Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Combination Antibody Therapy Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Combination Antibody Therapy Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Combination Antibody Therapy Market Size Share by Type (2015-2020)
Table 26. Global Combination Antibody Therapy Revenue Market Share by Type (2021-2026)
Table 27. Global Combination Antibody Therapy Market Size Share by Application (2015-2020)
Table 28. Global Combination Antibody Therapy Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Combination Antibody Therapy Market Size Share by Application (2021-2026)
Table 30. North America Combination Antibody Therapy Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Combination Antibody Therapy Market Share by Type (2015-2020)
Table 32. North America Combination Antibody Therapy Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Combination Antibody Therapy Market Share by Application (2015-2020)
Table 34. North America Combination Antibody Therapy Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Combination Antibody Therapy Market Share by Country (2015-2020)
Table 36. Europe Combination Antibody Therapy Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Combination Antibody Therapy Market Share by Type (2015-2020)
Table 38. Europe Combination Antibody Therapy Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Combination Antibody Therapy Market Share by Application (2015-2020)
Table 40. Europe Combination Antibody Therapy Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Combination Antibody Therapy Market Share by Country (2015-2020)
Table 42. China Combination Antibody Therapy Market Size by Type (2015-2020) (US$ Million)
Table 43. China Combination Antibody Therapy Market Share by Type (2015-2020)
Table 44. China Combination Antibody Therapy Market Size by Application (2015-2020) (US$ Million)
Table 45. China Combination Antibody Therapy Market Share by Application (2015-2020)
Table 46. China Combination Antibody Therapy Market Size by Region (US$ Million) (2015-2020)
Table 47. China Combination Antibody Therapy Market Share by Region (2015-2020)
Table 48. Japan Combination Antibody Therapy Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Combination Antibody Therapy Market Share by Type (2015-2020)
Table 50. Japan Combination Antibody Therapy Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Combination Antibody Therapy Market Share by Application (2015-2020)
Table 52. Japan Combination Antibody Therapy Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Combination Antibody Therapy Market Share by Country (2015-2020)
Table 54. Southeast Asia Combination Antibody Therapy Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Combination Antibody Therapy Market Share by Type (2015-2020)
Table 56. Southeast Asia Combination Antibody Therapy Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Combination Antibody Therapy Market Share by Application (2015-2020)
Table 58. Southeast Asia Combination Antibody Therapy Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Combination Antibody Therapy Market Share by Country (2015-2020)
Table 60. Biogen Company Details
Table 61. Biogen Business Overview
Table 62. Biogen Product
Table 63. Biogen Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 64. Biogen Recent Development
Table 65. Roche Holdings Company Details
Table 66. Roche Holdings Business Overview
Table 67. Roche Holdings Product
Table 68. Roche Holdings Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 69. Roche Holdings Recent Development
Table 70. Seattle Genetics Company Details
Table 71. Seattle Genetics Business Overview
Table 72. Seattle Genetics Product
Table 73. Seattle Genetics Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 74. Seattle Genetics Recent Development
Table 75. Amgen Company Details
Table 76. Amgen Business Overview
Table 77. Amgen Product
Table 78. Amgen Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 79. Amgen Recent Development
Table 80. Bristol-Myers Squibb Company Details
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Eli Lilly Company Details
Table 86. Eli Lilly Business Overview
Table 87. Eli Lilly Product
Table 88. Eli Lilly Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 89. Eli Lilly Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 94. Novartis Recent Development
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Company Details
Table 98. Sanofi Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Celgene Company Details
Table 101. Celgene Business Overview
Table 102. Celgene Product
Table 103. Celgene Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 104. Celgene Recent Development
Table 105. Genmab Company Details
Table 106. Genmab Business Overview
Table 107. Genmab Product
Table 108. Genmab Revenue in Combination Antibody Therapy Business (2015-2020) (US$ Million)
Table 109. Genmab Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Combination Antibody Therapy Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy/Antibody Features
Figure 3. Antibody/Antibody Features
Figure 4. Conjugated Antibodies Features
Figure 5. Bispecific Antibodies Features
Figure 6. Global Combination Antibody Therapy Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Clinics Case Studies
Figure 10. ASCs Case Studies
Figure 11. Combination Antibody Therapy Report Years Considered
Figure 12. Global Combination Antibody Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Combination Antibody Therapy Market Share by Regions: 2020 VS 2026
Figure 14. Global Combination Antibody Therapy Market Share by Regions (2021-2026)
Figure 15. Global Combination Antibody Therapy Market Share by Players in 2019
Figure 16. Global Top Combination Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Combination Antibody Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Combination Antibody Therapy Revenue in 2019
Figure 18. North America Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Combination Antibody Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 46. Roche Holdings Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 47. Seattle Genetics Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 48. Amgen Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 50. Eli Lilly Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 51. Novartis Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 52. Sanofi Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 53. Celgene Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 54. Genmab Revenue Growth Rate in Combination Antibody Therapy Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Keyplayers in Global and China Combination Antibody Therapy Market Size, Status and Forecast 2020-2026
BiogenRoche Holdings
Seattle Genetics
Amgen
Bristol-Myers Squibb
Eli Lilly
Novartis
Sanofi
Celgene
Genmab